Obesity, asthma and allergy triangle: the solution could be the diet

November 2026 Volume 137, Issue 5, Pages 545-554  CME Review 

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:  

• Describe the epidemiological and mechanistic relationships between obesity, asthma, and allergic diseases in children and identify the key factors contributing to disease development.

• Interpret how dietary patterns influence metabolic and immune pathways involved in the obesity–asthma–allergy triad and apply this knowledge to support preventive and therapeutic strategies.

Additional information
Disclosure: 

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, the ACAAI requires that all individuals in a position to control or influence the content of an activity disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients.

All relevant financial relationships with ineligible companies have been reviewed and mitigated prior to this activity.

Copyright Statement: ©2015-2026  ACAAI. All rights reserved.
CME Inquiries: Contact the American College of Allergy, Asthma & Immunology at [email protected] or 847-427-1200.

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
11/01/2026
Course expires: 
12/31/2027
Rating: 
0

Planners:

•  Anna Nowak-Wegrzyn, MD, PhD, FACAAI, has no relevant financial relationships with ineligible companies to disclose.
•  Kurt Shulenberger, MA, has no relevant financial relationships with ineligible companies to disclose

Authors:
•  Serena Coppola, RDN, has no relevant financial relationships with ineligible companies to disclose
•  Alessandra Agizza, BS, has no relevant financial relationships with ineligible companies to disclose.
•  Raffaele Federico Iorio, MD, has no relevant financial relationships with ineligible companies to disclose.
•  Laura Carucci, MD, PhD, has no relevant financial relationships with ineligible companies to disclose.
•  Franca Oglio, BS, has no relevant financial relationships with ineligible companies to disclose.
•  Erika Caldaria, MD, has no relevant financial relationships with ineligible companies to disclose
•  Alessia Cadavere, BS, has no relevant financial relationships with ineligible companies to disclose.
•  Roberto Berni Canani, MD, PhD, has no relevant financial relationships with ineligible companies to disclose.
 

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Please login or create an account to take this course.